Sirvent, A., Lafitte, M., & Roche, S. (2018). DDR1 inhibition as a new therapeutic strategy for colorectal cancer. Mol Cell Oncol.
استشهاد بنمط شيكاغوSirvent, Audrey, Marie Lafitte, و Serge Roche. "DDR1 Inhibition As a New Therapeutic Strategy for Colorectal Cancer." Mol Cell Oncol 2018.
MLA استشهادSirvent, Audrey, Marie Lafitte, و Serge Roche. "DDR1 Inhibition As a New Therapeutic Strategy for Colorectal Cancer." Mol Cell Oncol 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.